首页> 外文OA文献 >Multicentre Hospital-based Case-control Study of Diffuse Large B-cell Lymphoma in Shanghai, China

【2h】

Multicentre Hospital-based Case-control Study of Diffuse Large B-cell Lymphoma in Shanghai, China

机译：中国上海上海弥漫性大B细胞淋巴瘤的多长期医院案例对照研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Rong Fan; Lu-Yao Zhang; Hong Wang; Bo Yang; Tao Han; Xiao-Li Zhao; Wei Wang; Xiao-Qin Wang; Guo-Wei Lin;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Multicentre Hospital-based Case-control Study of Diffuse Large B-cell Lymphoma in Shanghai, China [J] . Rong Fan, Lu-Yao Zhang, Hong Wang, Asian Pacific Journal of Cancer Prevention . 2012,第7期

机译：中国上海上海弥漫性大B细胞淋巴瘤的多长期医院案例对照研究
2. Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study [J] . Jianqiu Wu, Yongping Song, Liping Su, BMC Cancer . 2016,第1期

机译：利妥昔单抗联合化学疗法作为中国弥漫性大B细胞淋巴瘤患者常规治疗的一线治疗：一项前瞻性，多中心，非干预性研究
3. A multicentre retrospective study of primary breast diffuse large B-cell and high-grade B-cell lymphoma treatment strategies and survival [J] . Zeitschrift fur Arznei- und Gewurzpflanzen . 2020,第1期

机译：原发性乳腺弥漫性大型B细胞和高级B细胞淋巴瘤治疗策略和生存的多期回顾性研究
4. Pathological Analysis of Diffuse Large B-Cell Lymphoma and Clinical Treatment with Chinese and Western Medicine [C] . Xianhui Liu, Xiaona Guo, Chunsheng Yan International Conference on Management, Education, Information and Control . 2016

机译：弥漫性大B细胞淋巴瘤的病理分析及中西医临床治疗
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective multicentre non-interventional study [O] . Jianqiu Wu, Yongping Song, Liping Su, 2016

机译：利妥昔单抗联合化学疗法作为中国弥漫性大B细胞淋巴瘤患者常规治疗的一线治疗：一项前瞻性多中心非干预性研究
7. Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study [O] . 2016

机译：利妥昔单抗联合化学疗法作为中国弥漫性大B细胞淋巴瘤患者常规治疗的一线治疗：一项前瞻性，多中心，非干预性研究
8. Slide Presentation Presented at the International Benzene Symposium in Munich, Germany Which Consists of a Summary of the Results of a Case-control Study of Acute Myeloid Leukemia (AML) and Non-Hodgkin Lymphoid Neoplasms (NHLN), Conducted in Shanghai, China with Benzene. [R] . 2009

机译：幻灯片介绍在德国慕尼黑举行的国际苯研讨会上发表，该研讨会由中国上海与苯进行的急性髓性白血病（amL）和非霍奇金淋巴样肿瘤（NHLN）病例对照研究结果汇总。

Multicentre Hospital-based Case-control Study of Diffuse Large B-cell Lymphoma in Shanghai, China

著录项

引文网络

相似文献

相关主题

期刊订阅